This dynamic lunch symposium spotlights how routine preoperative hereditary cancer genetic testing with the MyRisk® Hereditary Cancer Test can sharpen surgical planning and elevate long term patient management. Through concise, evidence-based insights from leading CRC experts, attendees will see how early genetic risk identification can inform operative decisions, streamline multidisciplinary coordination, and support more precise colorectal cancer care. This session will also explore practical workflows utilizing Myriad’s suite of services and showcase how a leading cancer center has implemented them in real-world practice.
Speakers:
Paul Johnson, MD, M.M.Sc, FACS, FASCRS | Methodist Cancer Institute
Vitaliy Y. Poylin, MD | Northwestern Medicine Digestive Health Center
Location:Embassy Suites, Gandy Room
Register Now